Drugs / Umbilical Cord Mesenchymal Stem Cell
Umbilical Cord Mesenchymal Stem Cell
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT03800810 | May 2015 → May 2019 | osteoarthritis, knee | Indonesia University | Unknown | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT07131540 | Jan 2026 → Dec 2031 expected | liver disorder | Institute of Liver and Biliary Sciences, India | Not yet recruiting | No outcome recorded |
| Phase 1/24 trials | ||||||
| Phase 1/2 | NCT06505941 | Jul 2024 → Nov 2025 overdue | acute respiratory distress syndrome | Southeast University, China | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT06448052 | Nov 2023 → Jan 2026 overdue | diabetes mellitus, inflammatory disease, obesity disorder | Nguyen Ton Ngoc Huynh | Active not recruiting | No outcome recorded |
| Phase 1/2 | NCT06492798 | Sep 2023 → Jul 2025 overdue | long COVID-19 | Changhai Hospital | Recruiting | No outcome recorded |
| Phase 1/2 | NCT02285673 | Nov 2013 → Feb 2015 | Duchenne muscular dystrophy | Acibadem University | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03378414 | Dec 2026 → Jun 2027 expected | Machado-Joseph disease, spinocerebellar ataxia type 1, spinocerebellar ataxia type 2, spinocerebellar ataxia type 6 | Sclnow Biotechnology Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05935423 | Jul 2023 → Jul 2024 | ST-elevation myocardial infarction | Indonesia University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04315025 Comparator | Oct 2018 → Jun 2019 | retinitis pigmentosa | PT. Prodia Stem Cell Indonesia | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | umbilical cord mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03378414 ↗ |
| Known as | 19#iSCLife-SA | “Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia” NCT03378414 ↗ |
| Known as | hUC-MSCs | “The stem cells used in this study are human umbilical cord mesenchymal stem cells (hUC-MSCs), which are derived from umbilical cords donated by healthy mothers who have given...” NCT06505941 ↗ |
| Known as | SCLnow 19# | “Treat patients with umbilical cord mesenchymal stem cell (SCLnow 19#), the dosage based on different procedure” NCT03378414 ↗ |
| Known as | UC-MSC | “Patients assigned in UC-MSC intervention group will get Umbilical Cord Mesenchymal Stem Cell transplantation” NCT05935423 ↗3“Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Spinocerebellar Ataxia” NCT03378414 ↗ “Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar” NCT04315025 ↗ “Umbilical cord mesenchymal stem cell (UC-MSC) transplantation” NCT06448052 ↗ |
| Modality | Cell therapy | “Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy” NCT03378414 ↗ |
| Route | Intravenous | “Intravenous infusion of mesenchymal stem cells” NCT03378414 ↗ |